A volunteer model for the comparison of laxatives in opioid-related constipation

Journal of Pain and Symptom Management

Volumn 11, Issue 6, 1996, Pages 363-369

  Sykes, Nigel P ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST CHRISTOPHER S HOSPICE   (United Kingdom)

Author keywords

cathartics; Constipation; loperamide; opioids; terminal care

Indexed keywords

LACTULOSE; LOPERAMIDE; OPIATE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; HUMAN; HUMAN EXPERIMENT; INTESTINE FUNCTION; INTESTINE TRANSIT TIME; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PALLIATIVE THERAPY; PERISTALSIS; SENNA; TERMINAL CARE; VOLUNTEER;

EID: 0030005433     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/0885-3924(96)00011-5     Document Type: Article

References (19)

1. Wuster M, Herz A. Opiate agonist action of antidiarrhoeal agents in vitro and in vivo findings in support for selective actions. Naunyn Schmiedebergs Arch Pharmacol 1978;301:187-194.
2. Heel RC, Brogden RN, Speight TM, Avery GS. Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea. Drugs 1978;15:33-52.
3. Ruppin H. Review: loperamide - a potent antidiarrhoeal drug with actions along the alimentary tract. Aliment Pharmacol Ther 1987;1:179-90.
4. Snisky CA, Davis RH, Clench MH, Thomas KD, Mathias JR. Effect of lidamidine hydrochloride and loperamide on gastric emptying and transit of the small intestine. Gastroenterology 1986;90:68-73.
5. Read M, Read NW, Barber CD, Duthie HL. Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhoea with faecal incontinence and urgency. Dig Dis Sci 1982;27: 807-814.
6. Basilisco G, Camboni G, Bozzani A, Paravicini M, Bianchi PA. Oral naloxone antagonizes loperamide-induced delay of orocaecal transit. Dig Dis Sci 1987;32:829-832.
7. Niemegeers CJE, Lenaerts FM, Janssen PAJ. Loperamide (R18553), a novel type of antidiarrhoeal agent. Part 2. Arzneimittelforschung (Drug Res) 1974;24:1633-1665.
8. Bateman DN, Smith JN. A policy for laxatives. BMJ 1988;297:1420-1421.
9. Maguire LC, Yon JL, Miller E. Prevention of narcotic-induced constipation. N Engl J Med 1981; 305:1651.
10. Brunton LL. Agents affecting gastrointestinal water flux and motility, digestants, and bile acids. In: Gilman AG, Rall TW, Xis AS, Taylor P, eds. The pharmacological basis of therapeutics, 8th ed. New York: Pergamon, 1990.
11. Davies GJ, Crowder M, Reid B, Dickerson JWT. Bowel function measurements of individuals with different eating patterns. Gut 1986;27:164-169.
12. Perkin JM. Constipation in childhood: a controlled comparison between lactulose and standardised senna. Curr Med Res Opin 1977;4:540-543.
13. Sykes NP. Methods of assessment of bowel function in patients with advanced cancer. Palliat Med 1990;4:287-292.
14. Monthly Index of Medical Specialities. London: Haymarket, 1995 (August).
15. Margolin S. Decreased gastrointestinal propulsive activity after intracranial morphine. Fed Proc 1954;13:383-384.
16. Manara L, Bianchi G, Ferretti P, Tavani A. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. J Pharmacol Exp Ther 1986;237:945-948.
17. Manara L, Bianchi G, Ferretti P, Monferini E, Strada D, Tavani A. Local and CNS-mediated effects of morphine and narcotic antagonists on gastrointestinal propulsion in rats. In: Way EL, ed. Endogenous and exogenous opiate agonists and antagonists. New York: Pergamon, 1980.
18. 3H in normal and narcoticdependent men. J Pharmacol Exp Ther 1973;187: 575-580.
19. Kreek MJ, Paris P, Bartol MA, Mueller D. Effects of short term oral administration of the specific opioid antagonist naloxone on faecal evacuation in geriatric patients. Gastroenterol 1984;86:1144.